Search the Newsreel

Insight Molecular Diagnostics Inc. Revenue Breakdown – LSE:0KCC

Insight Molecular Diagnostics Inc. (LSE:0KCC) generated significant revenue last year, primarily from its Diagnostic Tests segment. The company's top segment contributed $4.05 million USD, an increase from $1.88 million USD in the prior year. The United States was the largest geographical contributor, accounting for …

Insight Enterprises (NSIT) Following AI And Cloud Demand Narrative Faces A Valuation Test

Insight Enterprises (NSIT) stock has recently seen a 90-day surge but a 1-year decline, closing at $117.65. While a narrative fair value suggests it's overvalued at $107.50 due to its AI and cloud exposure, another view based on its P/E ratio of 19.8x suggests …

INTS|Intensity Therapeutics Inc|Price:4.450|Chg%:+0.030

Intensity Therapeutics Inc. (INTS) closed at $4.45 with a 0.68% increase. The company, a late-stage clinical biotechnology firm, is developing treatments for cancer with its lead product candidate, INT230-6, currently in Phase 3 trials. Analysts rate the stock as a "Buy" with a target …

The Ensign Group, Inc. Revenue Breakdown – NASDAQ:ENSG

The Ensign Group, Inc. (NASDAQ: ENSG) generated $5.06 billion USD in revenue last year, primarily from its Skilled Services segment, which contributed $4.84 billion USD. The United States was the company's largest regional contributor, accounting for the entire $5.06 billion USD in revenue.

Expensify, Inc. Revenue Breakdown – NASDAQ:EXFY

Insight Enterprises (NSIT) Stock Looks Cheap On Fair Value After A 40% Run

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Insight Enterprises stock has climbed 40.1% year to date, and with both its intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and …

SXT|Sensient Technologies Corp|Price:133.470|Chg%:+3.665

Sensient Technologies Corp (SXT) is a manufacturer and marketer of colors, flavors, and other specialty ingredients, with segments including Flavors & Extracts, Color, and Asia Pacific. The company serves both food and non-food industries. As of Q1 2026, institutional shareholding increased, and the Food …

SXT|Sensient Technologies Corp|Price:130.396|Chg%:+0.406

Sensient Technologies Corp (SXT) is a manufacturer and marketer of colors, flavors, and other specialty ingredients, with segments including Flavors & Extracts, Color, and Asia Pacific. The company serves both food and non-food industries. As of Q1 2026, institutional shareholding increased, and the Food …

SXT|Sensient Technologies Corp|Price:131.545|Chg%:+2.185

Sensient Technologies Corp (SXT) is a manufacturer and marketer of colors, flavors, and other specialty ingredients, with segments including Flavors & Extracts, Color, and Asia Pacific. The company serves both food and non-food industries. As of Q1 2026, institutional shareholding increased, and the Food …

Nano Dimension Ltd (NNDM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Nano Dimension Ltd (NNDM), categorizing its income by business segments and geographical regions. As of Q3 FY2025, Hardware sales contribute 54.55% of revenue, followed by Consumables at 27.64% and Service at 17.82%. Regionally, the United States …

Insight Molecular Diagnostics Ord Shs (IMDX) Institutional Confidence

This article provides details on the institutional confidence in Insight Molecular Diagnostics Ord Shs (IMDX), listing key institutional shareholders and their recent changes in shareholdings. It highlights major holders like Broadwood Capital, Inc. and AWM Investment Company, Inc., along with their respective percentage changes …

AdvanSix Inc (ASIX) Institutional Confidence

The article analyzes AdvanSix Inc's (ASIX) institutional confidence, noting its score of 10.00, which ranks 1st in the Chemicals industry. Institutional shareholding proportion is 90.39%, a 9.30% decrease quarter-over-quarter. Donald G. Smith is the largest institutional shareholder with 243.60K shares.

PT Asuransi Tugu Pratama Indonesia Tbk Revenue Breakdown – IDX:TUGU

NSIT|Insight Enterprises Inc|Price:117.650|Chg%:+1.990

This article provides a comprehensive stock analysis of Insight Enterprises Inc (NSIT) by TradingKey, highlighting its strong fundamentals, high growth potential, and "fairly valued" status. The company, a global solutions integrator, has high institutional ownership and analysts generally rate it as a "Buy" with …

Nano Dimension Ltd (NNDM) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Nano Dimension Ltd (NNDM), outlining major shareholders, institutional holdings, and shareholder activity. It provides a breakdown of shareholder types, including investment advisors, corporations, and hedge funds, along with changes in institutional holdings over recent quarters. The report …

Ensign Group, Inc expected to post earnings of $1.84 a share - Earnings Preview

Ensign Group, Inc. is projected to report earnings of $1.84 per share. This information is presented as an earnings preview from Reuters and Refinitiv. The full news content is behind a 30-day free trial on TradingView.

Sensient Technologies Corp (SXT) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ...

This article first appeared on GuruFocus. Revenue: $462.1 million in Q2 2026, up from $414.2 million in Q2 2025. Local Currency Revenue Growth: 10% in Q2 2026. Adjusted EBITDA Growth: 21% in local currency for Q2 2026. Adjusted EPS Growth: 26% in local currency …

AdvanSix Inc. Revenue Breakdown – NYSE:ASIX

This article provides a detailed revenue breakdown for AdvanSix Inc (ASIX) by business segment and geographical region. As of April 6 (Year unspecified, presumably 2025 based on fiscal year data), the company's revenue is primarily driven by Chemical Intermediates (37.03%), Plant Nutrients (24.80%), Nylon …

Sensient anticipates mid-to-high teens 2026 adjusted EBITDA and EPS growth while targeting $1B natural color sales

Earnings Call Insights: Sensient Technologies Corporation (SXT) Q2 2026 MANAGEMENT VIEW * “We delivered 10% local currency revenue growth, 21% local currency adjusted EBITDA growth and 26% local currency adjusted EPS growth in the second quarter,” said (Chairman, CEO, President & Member of Scientific …

Insight Enterprises Inc (NSIT) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Insight Enterprises Inc (NSIT), identifying its major institutional holders such as BlackRock, Vanguard, and Fidelity. It breaks down shareholder types by proportion, providing insights into the institutional ownership landscape. The report also includes historical institutional shareholding data …

Insight Enterprises Inc (NSIT) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Insight Enterprises Inc (NSIT), highlighting its current earnings forecast score of 7.50 and ranking within the Software & IT Services industry. It details analyst ratings, target prices, and expected future revenue and EPS, indicating a general "Buy" …

Sensient Technologies Corporation Reports Results for the Quarter Ended June 30, 2026

Sensient Technologies Corporation (NYSE: SXT) reported strong financial results for the second quarter ended June 30, 2026, with reported revenue increasing 11.6% to $462.1 million and reported earnings per share rising 36.4% to $1.20. The company saw significant growth across its Flavors & Extracts, …

Earnings call transcript: Sensient tops Q2 2026 estimates on color demand

Sensient Technologies reported strong second-quarter 2026 results, surpassing Wall Street expectations with adjusted earnings of $1.20 per share on $462.1 million in revenue, driven by accelerating demand for natural colors. The company raised its full-year 2026 guidance, expecting high single-digit to low double-digit local …

SXT Stock Climbs As Dividend And Analyst Views Shape Trading

Sensient Technologies Corporation (SXT) stock has risen by 7.11% following strong quarterly earnings and a declared quarterly dividend of $0.41. Analyst views are mixed, with Rothschild & Co Redburn initiating coverage at Neutral with a $125 price target due to rich valuation, while the …

IMDX|Insight Molecular Diagnostics Ord Shs|Price:4.960|Chg%:-0.030

This page provides a detailed overview of Insight Molecular Diagnostics Ord Shs (IMDX), including its current stock price, key financial figures, and recent performance. The company's stock closed at $4.730, experiencing a 4.64% decrease. Analyst ratings suggest a "Buy" with a significant upside, despite …

SENSIENT TECHNOLOGIES ($SXT) Releases Q2 2026 Earnings

Sensient Technologies Non-GAAP EPS of $1.20 beats by $0.17, revenue of $462.1M beats by $13.26M

* Sensient Technologies press release [https://seekingalpha.com/pr/20594462-sensient-technologies-corporation-reports-results-for-the-quarter-ended-june-30-2026] (SXT [https://seekingalpha.com/symbol/SXT]): Q2 Non-GAAP EPS of $1.20 beats by $0.17. * Revenue of $462.1M (+11.6% Y/Y) beats by $13.26M. * FY26 EPS consensus of $3.92 * 2026 OUTLOOK Metric Current Guidance Prior Guidance Local Currency Revenue(1) High Single-Digit …

Sensient Technologies Boosts FY26 EPS Outlook - Update

(RTTNews) - While reporting financial results for the second quarter on Friday, Sensient Technologies Corp. (SXT) raised its earnings guidance for the full-year 2026, while trimming annual revenue growth outlook. For fiscal 2026, the company now projects earnings in a range of $4.10 to …

Sensient's Color Revenue Rises 20.6% to $216 Million in Q2

Sensient Technologies Corporation reported strong financial results for the second quarter ended June 30, 2026, with reported revenue increasing 11.6% to $462.1 million and reported earnings per share rising 36.4% to $1.20. The Color Group was a key driver of growth, with its revenue …

Medicare coverage confirmed for iMDx kidney-rejection monitoring test

Insight Molecular Diagnostics (iMDx) announced that a new Lancet study demonstrated its GraftAssure donor-derived cell-free DNA (dd-cfDNA) assay could guide treatment for antibody-mediated rejection in kidney transplant patients, potentially reducing drug use by two-thirds. The company also confirmed Medicare reimbursement coverage from MolDX for …

Kaplan Fox Notifies Investors of The Ensign Group, Inc. (NASDAQ: ENSG) of an Investigation Into Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against The Ensign Group, Inc. (NASDAQ: ENSG) following a report that alleges the company's business model relies on inadequate care and systematic misrepresentations. The report, titled "Ensign: The Nursing Home Empire Built On Fatal …

Nano Dimension and Murchinson Announce Agreement to Reconstitute the Company’s Board of Directors

Nano Dimension and Murchinson Ltd. have reached a settlement agreement to reconstitute Nano Dimension's Board of Directors. The July 31, 2026 Extraordinary General Meeting of Shareholders has been canceled, and four previous directors have resigned, while three directors nominated by Murchinson have been appointed …

INTS Q1 2026 Earnings: Narrower Loss Beats Estimates as Clinical Pipeline Advances - Financial Data

Sensient Technologies (NYSE:SXT) Sees Strong Trading Volume Following Earnings Beat

Sensient Technologies (NYSE:SXT) Updates FY 2026 Earnings Guidance

Sensient Technologies (NYSE:SXT) Announces Quarterly Earnings Results